21 CFR 812.42 – FDA and IRB approval
Current as of: 2024 | Check for updates
|
Other versions
A sponsor shall not begin an investigation or part of an investigation until an IRB and FDA have both approved the application or supplemental application relating to the investigation or part of an investigation.
